Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial

Kelly K Nichols,1 Edward Holland,2 Melissa M Toyos,3 James H Peace,4 Parag Majmudar,5 Aparna Raychaudhuri,6 Mohamed Hamdani,6 Monica Roy,6 Amir Shojaei6 1School of Optometry, University of Alabama at Birmingham, Birmingham, AL, 2Cincinnati Eye Institute, Edgewood, KY, 3Toyos Clinic, Nashville, TN,...

Full description

Bibliographic Details
Main Authors: Nichols KK, Holland E, Toyos MM, Peace JH, Majmudar P, Raychaudhuri A, Hamdani M, Roy M, Shojaei A
Format: Article
Language:English
Published: Dove Medical Press 2018-01-01
Series:Clinical Ophthalmology
Subjects:
drop comfort
dry eye disease
lifitegrast ophthalmic solution 5.0%
ocular comfort
OPUS-3
Online Access:https://www.dovepress.com/ocular-comfort-assessment-of-lifitegrast-ophthalmic-solution-50-in-opu-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/ocular-comfort-assessment-of-lifitegrast-ophthalmic-solution-50-in-opu-peer-reviewed-article-OPTH

Similar Items